📘 New Evidence from NEJM

In a large meta-analysis of 17,801 patients with preserved LVEF after MI, beta-blockers did not reduce death, recurrent MI, or heart failure. Event rates were low, and outcomes were similar with or without therapy. 🫀📊

This clarifies practice for a growing post-MI population with LVEF ≥50%—precision matters more than tradition. 🎯

Full study: New England Journal of Medicine (2025).

#Cardiology 💙 #ClinicalEvidence #MI #HeartHealth